AI주식인사이트AI Stock Insight
C

SCL사이언스

246960KOSDAQ

44.5 / 100

Reference Date: 2026-10-23

Financial Score11.0 / 40
News Sentiment12.5 / 25
Momentum9.0 / 20
Disclosure12.0 / 15
AI Analysis: ROE is below the industry average, PBR raises overvaluation concerns. Slightly down 1.5% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

SCL Science is a company specializing in protein-based platform technologies, offering hemostatic products, bio-logging services, and healthcare data platforms. In 2025, its consolidated sales reached 22,011 million KRW, reflecting a 365% increase driven by growth in bio-logging and data platform services. Key products include the 'InnoSEAL' hemostatic series, 'InTro' catheters, and AI-powered medical data solutions, with expansion into high-risk medical device markets and global bio-logging services.

Number of Employees

163people

Average Salary

77.3M KRW

Score Calculation Basis

Detailed Financial Score

PER
—Industry Average 15.004.0Point
PBR
3.30Industry Average 1.200.0Point

2.8x industry avg (risky)

ROE
-21.12Industry Average 8.000.0Point

Well below industry avg

Debt Ratio
134.87Industry Average 100.002.0Point

Higher than industry avg (caution)

Trend 2023~20255.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲311.5% (2-year basis)

Operating Profit Growth Rate
2.0 / 3

Avg ▲8.0% (2-year basis)

ROE Trend
0.0 / 4

Avg ROE -24.7% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position5.0Point

52w mid range (56%)

Current 2,280Won52-week high 2,92552-week low 1,440
1-month return3.0Point

1m -1.51% (flat)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

3 totalPositive 1Neutral 2Negative 0
  • Neutral전환청구권행사2026-10-16
  • Neutral기업설명회(IR)개최2026-10-06
  • Positive[기재정정]단일판매ㆍ공급계약체결2026-09-30